Opposing biological functions of the cytoplasm and nucleus DAXX modified by SUMO-2/3 in gastric cancer
2020 · Cell Death and Disease · 32 citations
https://doi.org/10.1038/s41419-020-2718-3
K
Kezhi Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
686
Citations
16
h-index
22
i10-index
Kezhi Lin is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Electrospun Nanofibers in Biomedical Applications & Wound Healing and Treatments & Cytomegalovirus and herpesvirus research. The author has an h-index of 16, co-authored 30 publications.
ORCID: 0000-0002-6350-2804Papers by this author
worksASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer
2023 · Cell Death and Disease · 25 citations
https://doi.org/10.1038/s41419-023-05648-9
Immunogenic cell death-based oncolytic virus therapy: A sharp sword of tumor immunotherapy
2024 · European Journal of Pharmacology · 18 citations
https://doi.org/10.1016/j.ejphar.2024.176913
LBA2 TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization (TACE) combined with atezolizumab + bevacizumab (Atezo+Bev) or on-demand TACE alone in patients with systemically untreated, intermediate-to-high burden unresectable hepatocellular carcinoma (uHCC)
2025 · Annals of Oncology · 15 citations
https://doi.org/10.1016/j.annonc.2025.05.542
NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB‐STAT3 signalling in a non‐m5C manner
2025 · Clinical and Translational Medicine · 2 citations
https://doi.org/10.1002/ctm2.70282
A rare concurrence of monoclonal gammopathies in an older adult with tubulointerstitial nephritis and uveitis syndrome
2025 · BMC Geriatrics · 0 citations
https://doi.org/10.1186/s12877-025-06151-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat